Nanjing (1)

Non-Hodgkin Lymphoma (1)

Relapsed and Refractory B Cell Lymphoma (1)

Recruiting (1)

early phase 1 (1)

Shanghai Longyao Biotechnology Inc., Ltd. (1)

cd20 car-t (1)

biological (1)

Other (1)

Interventional (1)

relapsed and refractory b cell lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Nanjing, Jiangsu, China

The First Affiliated Hospital with Nanjing Medical University

Nov 18, 2019